Pura Vida Investments, LLC Merus N.V. Transaction History

Pura Vida Investments, LLC

  • $151 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$18.64 - $28.93 $2.53 Million - $3.92 Million
135,632 New
135,632 $2.72 Million
Q2 2022

Aug 15, 2022
SELL
$13.98 - $29.25 $930,327 - $1.95 Million
-66,547 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$23.58 - $30.91 $185,975 - $243,787
7,887 Added 13.45%
66,547 $1.76 Million
Q4 2021

Feb 14, 2022
BUY
$20.0 - $32.29 $1.17 Million - $1.89 Million
58,660 New
58,660 $1.87 Million

Others Institutions Holding MRUS

# of Institutions
188
Shares Held
59M
Call Options Held
345K
Put Options Held
222K
View Full List

About Merus N.V.

MRUS Quotes by TradingView
  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $2.16B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email